Flexible Stenting Solutions has announced it has received FDA clearances for new sizes of its FlexStent biliary self-expanding stent system, according to a news release. The additional sizes include 9 ...

Cordis Acquires Flexible Stenting Solutions, Inc. Agreement Expands Treatment Options for Advanced Peripheral Artery Disease March 12, 2013 09:11 AM Eastern Daylight Time ...

The addition of Flexible Stenting Solutions’ FlexStent® Self Expanding Stent System provides Cordis with the opportunity to evolve the S.M.A.R.T.® Stent platform to address unmet needs in ...

FRESNO, Calif. (KFSN) -- About 27 million people in North America and Europe alone suffer from peripheral arterial disease or PAD. The disease limits blood flow to leg muscles, which can make it ...

Noninferiority was confirmed for the BioMatrix Flex stent compared with Cypher Select from the largest pool of evidence comparing a bioabsorbable and a durable polymer stent.

EATONTOWN, NJ Flexible Stenting Solutions, Inc. (FSS), a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today the successful implantation ...

New Jersey's Flexible Stenting Solutions snagged a CE mark for another device in its FlexStent family, a self-expanding device designed to treat atherosclerotic disease in the iliac arteries.

Cordis Corporation, a worldwide leader in the development of interventional vascular technology, said it has completed the acquisition of Flexible Stenting Solutions, Inc., a leading developer of ...

Even in experienced hands, the condition of the arterial access vasculature (eg, tortuous iliac, aortic arch type 3) can be a burden for successful device delivery. Therefore, it is of the utmost ...

There was no significant difference in the primary outcome of all-cause mortality, MI, stent thrombosis or stroke between the groups at 30 days, which occurred in 0.6% of patients in the aspirin ...

Cordis Acquires Flexible Stenting Solutions, Inc. Agreement Expands Treatment Options for Advanced Peripheral Artery Disease BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cordis Corporation, a worldwide ...